Headaches in brain tumor patients: Primary or secondary?

Headache

Volumn 54, Issue 4, 2014, Pages 776-785

  Nelson, Sarah ^a   Taylor, Lynne P ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

brain tumor; dura matter; headache

Indexed keywords

BLEEDING; BRAIN TUMOR; CARCINOMATOUS MENINGITIS; CHILDHOOD CANCER; COLLOID CYST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; FACE PAIN; HEADACHE; HYPOPHYSIS APOPLEXY; HYPOPHYSIS TUMOR; INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDER 3; MEDICAL LITERATURE; MEDICAL SOCIETY; NUMMULAR HEADACHE; PRIMARY HEADACHE; PRIMARY PITUITARY TUMOR; PRIORITY JOURNAL; REVIEW; SECONDARY HEADACHE; SELLA TURCICA TUMOR; TRIGEMINAL AUTONOMIC CEPHALALGIA; CLASSIFICATION; COMPLICATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES;

BRAIN NEOPLASMS; HEADACHE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES;

EID: 84897543998     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12326     Document Type: Review

References (89)

1. Purdy RA, Kirby S,. Headache and brain tumors. Neurol Clin N Am. 2004; 22: 39-53.
2. Headache Classification Subcommittee of the International Headache Society. The International classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013; 33: 629-808.
3. Bioardi A, Salmaggi A, Eoli M, et al. Headache in brain tumours: A symptom to reappraise critically. Neurol Sci. 2004; 25 (Suppl. 3): S143-S147.
4. Goffaux P, Fortin D,. Brain tumor headaches: From bedside to bench. Neurosurgery. 2010; 67: 459-466.
5. Schankin CJ, Ferrari U, Reinisch VM, et al. Characteristics of brain tumour-associated headache. Cephalalgia. 2007; 27: 904-911.
6. Suwanwela N, Phanthumchinda K, Kaoropthum S,. Headache in brain tumor: A cross-sectional study. Headache. 1994; 34: 435-438.
7. Chandana SR, Mowa S, Arora M, et al. Primary brain tumors in adults. Am Fam Physician. 2008; 77: 1423-1430.
8. Obermann M, Holle D, Naegel S, et al. Headache attributable to nonvascular intracranial disorders. Curr Pain Headache Rep. 2011; 15: 314-323.
9. Valentinis L, Tuniz F, Valent F,. Headache attributed to intracranial tumors: A prospective cohort study. Cephalalgia. 2010; 30: 389-398.
10. Forsyth PA, Posner JB,. Headaches in patients with brain tumors: A study of 111 patients. Neurology. 1993; 43: 1678-1683.
11. Loghin M, Levin VA,. Headache related to brain tumors. Curr Treat Options Neurol. 2006; 8: 21-32.
12. Pfund Z, Szapary L, Jaszberenyi O, et al. Headache in intracranial tumors. Cephalalgia. 1999; 19: 787-790.
13. Schankin CJ, Straube A,. Secondary headaches: Secondary or still primary? J Headache Pain. 2012; 13: 263-270.
14. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988; 8 (Suppl. 7): 1-96.
15. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004; 24: 1-160.
16. Wilne SH, Ferris RL, Nathwanti A,. The presenting features of brain tumors: A review of 200 cases. Arch Dis Child. 2006; 91: 502-506.
17. Ullrich NJ,. Neurologic sequelae of brain tumors in children. J Child Neurol. 2009; 24: 1446-1454.
18. Arruda MA, Albuquerque RC, Bigal ME,. Uncommon headache syndromes in the pediatric population. Curr Pain Headache Rep. 2011; 15: 280-288.
19. Hayashi N, Kidokoro H, Miyajima Y, et al. How do the clinical features of brain tumours in childhood progress before diagnosis? Brain Dev. 2010; 32: 636-641.
20. Klitbo DM, Nielsen R, Illum NO, et al. Symptoms and time to diagnosis in children with brain tumours. Dan Med Bull. 2011; 58: A4285.
21. Gondim JA, de Almeida JP, de Albuquerque LA, et al. Headache associated with pituitary tumors. J Headache Pain. 2009; 10: 15-20.
22. Levy MJ, Jager HR, Powell M, et al. Pituitary volume and headache: Size is not everything. Arch Neurol. 2004; 61: 721-725.
23. Levy MJ, Matharu MS, Meeran K, et al. The clinical characteristics of headache in patients with pituitary tumours. Brain. 2005; 128: 1921-1930.
24. Levy MJ,. The association of pituitary tumors and headache. Curr Neurol Neurosci Rep. 2011; 11: 164-170.
25. Anagnostis P, Adamidou F, Polyzos SA, et al. Non-functioning pituitary adenomas: A single center experience. Exp Clin Endocrinol Diabetes. 2011; 119: 314-319.
26. Fleseriu M, Yedinak C, Campbell C, et al. Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions. J Neurosurg. 2009; 110: 354-358.
27. Leung GK, Law HY, Hung KN, et al. Combined simultaneous transcranial and transsphenoidal resection of large-to-giant pituitary adenomas. Acta Neurochir (Wien). 2011; 153: 1401-1408.
28. Tao YX, Qu QY, Wang ZL, et al. Endoscopic transsphenoidal approach to pituitary adenomas invading the cavernous sinus. Chin Med J (Engl). 2010; 123: 3519-3523.
29. Shamim MS, Bari ME, Khursheed F, et al. Pituitary adenomas: Presentations and outcomes in a South Asian country. Can J Neurol Sci. 2008; 35: 198-203.
30. Bosco D, Belfiore A, Fava A, et al. Relationship between high prolactin levels and migraine attacks in patients with microprolactinoma. J Headache Pain. 2008; 9: 103-107.
31. Yang MS, Hong JW, Lee SK, et al. Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist. J Neurooncol. 2011; 104: 195-204.
32. Colao A, Di Somma C, Pivonello R, et al. Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer. 2008; 15: 905-915.
33. Turgut M, Ozsunar Y, Basak S, et al. Pituitary apoplexy: An overview of 186 cases published during the last century. Acta Neurochir (Wien). 2010; 152: 749-761.
34. Wang XL, Dou JT, Lu ZH, et al. Spontaneous remission of acromegaly or gigantism due to subclinical apoplexy of pituitary growth hormone adenoma. Chin Med J (Engl). 2011; 124: 3820-3823.
35. Zhang F, Chen J, Lu Y, et al. Manifestation, management and outcome of subclinical pituitary adenoma apoplexy. J Clin Neurosci. 2009; 16: 1273-1275.
36. Aui-aree N, Phruanchroen C, Oearsakul T, et al. Three years experience of suprasellar tumors in neuro-ophthalmology clinic. J Med Assoc Thai. 2010; 93: 818-823.
37. Raper DM, Besser M,. Clinical features, management and recurrence of symptomatic Rathke's cleft cyst. J Clin Neurosci. 2009; 16: 385-389.
38. Valassi E, Biller BM, Klibanski A, et al. Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol (Oxf). 2010; 73: 798-807.
39. Trucco M, Mainardi F, Maggioni F, et al. Chronic paroxysmal hemicrania, hemicrania continua and SUNCT syndrome in association with other pathologies: A review. Cephalalgia. 2004; 24: 173-184.
40. Evardsson B, Persson S,. Cluster headache and parietal glioblastoma multiforme. Neurologist. 2012; 18: 206-207.
41. Wilbrink LA, Ferrari MD, Kruit MC, et al. Neuroimaging in trigeminal autonomic cephalgias: When, how, and of what? Curr Opin Neurol. 2009; 22: 247-253.
42. Zidverc-Trajkovic J, Vujovic S, Sundic A, et al. Bilateral SUNCT-like headache in a patient with prolactinoma responsive to lamotrigine. J Headache Pain. 2009; 10: 469-472.
43. Leone M, Curone M, Mea E, et al. Cluster-tic syndrome resolved by removal of pituitary adenoma: The first case. Cephalalgia. 2004; 24: 1088-1089.
44. Chindia ML,. Intracranial tumour presenting with facial pain. Br Dent J. 1989; 166: 282-283.
45. Luyk NH, Hammond-Tooke G, Bishara SN, et al. Facial pain and muscle atrophy secondary to intracranial tumor. Br J Oral Maxillofac Surg. 1991; 29: 204-207.
46. Levitt SR, Spiegel EP, Claypoole WH,. The TMJ scale and undetected brain tumors in patients with temporomandibular disorders. Cranio. 1991; 9: 152-158.
47. Trumpy IG, Lyberg T,. Temporomandibular joint dysfunction and facial pain caused by neoplasms. Report of three cases. Oral Surg Oral Med Oral Pathol. 1993; 76: 149-152.
48. Ruffatti S, Zanchin G, Maggioni F,. A case of intractable facial pain secondary to metastatic lung cancer. Neurol Sci. 2008; 29: 117-119.
49. Capobianco DJ,. Facial pain as a symptom of nonmetastatic lung cancer. Headache. 1995; 35: 581-585.
50. Pareja JA, Caminero AB, Serra J, et al. Numular headache: A coin-shaped cephalgia. Neurology. 2002; 58: 1678-1679.
51. Grosberg BM, Solomon S, Lipton RB,. Nummular headache. Curr Pain Headache Rep. 2007; 11: 310-312.
52. Guillem A, Barriga FJ, Gimenez-Roldan S,. Nummular headache secondary to an intracranial mass lesion. Cephalalgia. 2007; 27: 943-944.
53. Guillem A, Barriga FJ, Gimenez-Roldan S,. Nummular headache associated to arachnoid cysts. J Headache Pain. 2009; 10: 215-217.
54. Alvaro LC, Garcia JM, Areitio E,. Nummular headache: A series with symptomatic and primary cases. Cephalalgia. 2009; 29: 379-383.
55. Sharp MC, MacArthur DC,. An unusual presentation of colloid cyst-implications for lifestyle advice. Br J Neurosurg. 2011; 25: 284-285.
56. Shaktawat SS, Salman WD, Twaij Z, et al. Unexpected death after headache due to a colloid cyst of the third ventricle. World J Surg Oncol. 2006; 4: 47.
57. Tamura Y, Uesugi T, Tucker A, et al. Hemorrhagic colloid cyst with intraventricular extension. J Neurosurg. 2013; 118: 498-501.
58. Kumar V, Behari S, Singh RK, et al. Pediatric colloid cysts of the third ventricle: Management considerations. Acta Neurochir. 2010; 152: 451-461.
59. Velander AJ, DeAngelis LM, Nabi BB,. Intracranial hemorrhage in patients with cancer. Curr Atheroscler Rep. 2012; 14: 373-381.
60. Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology. 2010; 74: 494-501.
61. Sato H, Hayashi N, Yamamoto H, et al. Synchronous multifocal osteosarcoma involving the skull presenting with intracranial hemorrhage. Neurol Med Chir (Tokyo). 2010; 50: 407-409.
62. Okura H, Yatomi K, Saito Y, et al. Unexpected intraparenchymal hematoma caused by brain metastasis in a patient with neuroblastoma. Neurol Med Chir (Tokyo). 2011; 51: 784-788.
63. Yamada T, Furukawa K, Yokoi K, et al. Case of meningeal carcinomatosis with gastric cancer which manifested meningeal signs as the initial symptom; the palliative benefit of radiotherapy. J Nippon Med Sch. 2008; 75: 216-220.
64. Fukuhara T, Saijo Y, Sakakibara T, et al. Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene. Tohoku J Exp Med. 2008; 214: 359-363.
65. Reardon DA, Zalutsky MR, Akabani G, et al. A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost. Neuro-Oncol. 2008; 10: 182-189.
66. Bhatt A, Farooq MU, Majid A, et al. Chemotherapy-related posterior reversible leukoencephalopathy syndrome. Nat Clin Pract Neurol. 2009; 5: 163-169.
67. Cohen MH, Shen YL, Keegan P, et al. FDA drug approval summary: Bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. Oncologist. 2009; 14: 1131-1138.
68. Cosar-Alas R, Alas A, Ozen A, et al. Capecitabine-related intracranial hypotension syndrome mimicking dural metastasis in a breast cancer patient: Case report and review of the literature. J Cancer Res Ther. 2010; 6: 557-559.
69. Figueiredo EG, Faria JW, Teixeira MJ,. Treatment of recurrent glioblastoma with intra-arterial BCNU [1,3-bis (2-chloroethyl)-1-nitrosourea. Arq Neuropsiquiatr. 2010; 68: 778-782.
70. Fox E, Aplenc R, Bagatell R, et al. A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors. J Clin Oncol. 2010; 28: 5174-5181.
71. Raizer JJ, Grimm S, Chamberlain MC, et al. A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas. Cancer. 2010; 116: 5297-5305.
72. Wen PY, Schiff D, Cloughesy TF, et al. A phase II study evaluating the efficacy and safety of AMG 102 (rilotomumab) in patients with recurrent glioblastoma. Neuro-Oncol. 2011; 13: 437-446.
73. Guerra Y, Lacuesta E, Marquez F, et al. Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer. Pituitary. 2010; 13: 54-59.
74. De Oliveira R, Pereira CU, Sallum AMC, et al. Immediate post-craniotomy headache. Cephalalgia. 2013; 0: 1-9.
75. De Gray LC, Matta BF,. Acute and chronic pain following craniotomy: A review. Anaesthesia. 2005; 60: 693-704.
76. Wan H, Chihiro O, Yuan S,. MASEP gamma knife radiosurgery for secretory pituitary adenomas: Experience in 347 consecutive cases. J Exp Clin Cancer Res. 2009; 28: 36.
77. Buis DR, van der Valk P, De Witt Hammer PC,. Subcutaneous tumor seeding after biopsy in gliomatosis cerebri. J Neurooncol. 2012; 106: 431-435.
78. Kozminski M,. Expert opinion: Trigeminal autonomic cephalgia post transsphenoidal surgery. Headache. 2008; 48: 658-659.
79. Shuper A, Packer RJ, Vezina G, et al. "Complicated migraine-like episodes" in children following cranial irradiation and chemotherapy. Neurology. 1995; 45: 1837-1840.
80. Black DF, Bartleson JD, Bell ML, et al. SMART: Stroke-like migraine attacks after radiation therapy. Cephalalgia. 2006; 26: 1137-1142.
81. Murthy SN, Cohen ME,. Pseudomigraine with prolonged aphasia in a child with cranial irradiation for medulloblastoma. J Child Neurol. 2002; 17: 134-138.
82. Bartleson JD, Krecke KN, O'Neill BP, et al. Reversible, strokelike migraine attacks in patients with previous radiation therapy. Neuro-Oncol. 2003; 5: 121-127.
83. Partap S, Walker M, Longstreth WT Jr, et al. Prolonged but reversible migraine-like episodes long after cranial irradiation. Neurology. 2006; 66: 1105-1107.
84. Kerklaan JP, Lycklama A, Nijeholt GJ, et al. SMART syndrome: A late reversible complication after radiation therapy for brain tumours. J Neurol. 2011; 258: 1098-1104.
85. Pruitt A, Dalmau J, Detre J, et al. Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology. 2006; 67: 676-678.
86. Bradshaw J, Chen L, Saling M, et al. Neurocognitive recovery in SMART syndrome: A case report. Cephalalgia. 2011; 31: 372-376.
87. Maloney PR, Rabinstein AA, Daniels D, et al. Surgically induced SMART syndrome: Case report and review of the literature. World Neurosurg. 2013; doi: 10.1016/j.wneu.2013.01.028.
88. Sheehan J,. SMART syndrome: A reversible complication after radiation therapy and surgery for brain tumors. World Neurosurg. 2013; doi: 10.1016/j.wneu.2013.01.101.
89. Armstrong AE, Gillan E, Dimario FJ,. SMART syndrome (stroke-like migraine attacks after radiation therapy) in adult and pediatric patients. J Child Neurol. 2014; 29: 336-341.